Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013;18(5):584-91.
doi: 10.1634/theoncologist.2012-0415. Epub 2013 May 1.

Prospective head and neck cancer research: a four-decade bibliometric perspective

Affiliations

Prospective head and neck cancer research: a four-decade bibliometric perspective

Gordon H Sun et al. Oncologist. 2013.

Abstract

Background: It is unknown whether changes in study sponsorship have affected the proportion of prospective research on surgery, radiotherapy, and pharmacotherapy for head and neck squamous cell carcinoma (HNSCC) being published over time.

Patients and methods: We examined prospective studies from PubMed, Ovid MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials from 1980, 1985, 1990, 1995, 2000, 2005, and 2010. Chi-squared tests were used to identify significant associations between sponsorship and authorship, treatments within study protocols, and presentation of results, whereas time-based trends were analyzed using the Cochran-Armitage test.

Results: Among 309 articles, industry (70, 22.7%) and the U.S. government (65, 21%) were the most common sponsors. There was a significant increase in the proportion of industry-sponsored research (p for trend = .013) and a decline in U.S. government-sponsored research (p for trend = .001) over time. The inclusion of surgery in treatment protocols declined over the past four decades (p for trend = .003). Protocols incorporating pharmacotherapy were more likely to have industry support than those without pharmacotherapy (p = .001), whereas protocols with radiotherapy (p = .003) or surgery (p = .002) were less likely to have industry support.

Conclusion: Industry is the predominant sponsor of prospective HNSCC research, with an emphasis on pharmacotherapy.

Keywords: Bibliometrics; Chemotherapy; Funding; Otolaryngology; Radiotherapy; Surgery.

PubMed Disclaimer

Conflict of interest statement

Disclosures of potential conflicts of interest may be found at the end of this article.

Figures

Figure 1.
Figure 1.
Categorized by continent of origin. (A) First authorship (n = 309). Studies may have more than one sponsor. (B) Corresponding authorship (n = 305). Study protocols may include more than one type of therapy.
Figure 2.
Figure 2.
Number of studies with a reported sponsor. Studies may have more than one sponsor. Abbreviation: NIH, National Institutes of Health.
Figure 3.
Figure 3.
Percentage of studies incorporating a given therapy within study protocols. Study protocols may include more than one type of therapy.

References

    1. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–2917. - PubMed
    1. Marur S, Forastiere AA. Head and neck cancer: Changing epidemiology, diagnosis, and treatment. Mayo Clin Proc. 2008;83:489–501. - PubMed
    1. Collins TR. Lecturer Warns Against Overuse of CRT: Says Many Early-Stage Laryngeal Cancer Patients Overtreated. ENT Today. [Accessed September 25, 2012]. Available at http://www.enttoday.org/details/article/1074133/Lecturer_Warns_Against_O....
    1. Hoffman HT, Porter K, Karnell LH, et al. Laryngeal cancer in the United States: Changes in demographics, patterns of care, and survival. Laryngoscope. 2006;116:1–13. - PubMed
    1. Moyer JS, Wolf GT, Bradford CR. Current thoughts on the role of chemotherapy and radiation in advanced head and neck cancer. Curr Opin Otolaryngol Head Neck Surg. 2004;12:82–87. - PubMed